ArticleFrontiers in pediatrics2026
Case Report: ETV6 c.744del gene mutation acute lymphoblastic leukemia in identical twins.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It is extremely rare for monozygotic twins to both develop leukemia. This paper reports a clinical case in which a pair of monozygotic twins with germline ETV6 gene mutations successively developed acute lymphoblastic leukemia (B-cell type, ALL-B). The ETV6:c.744del (p.S248fs) is a novel germline mutation associated with familial susceptibility to hematologic malignancies. This mutation site has not been detected in relevant databases or literature, and this is the first international report of it. It provides reference value for genetic screening of such diseases. Case introduction: The elder twin (2 years old) presented with fever and skin petechiae; the younger twin (4 years old) presented with knee joint pain and lymphadenopathy. Both were diagnosed with B-cell ALL. Germline ETV6 c.744del was confirmed using DNA from buccal swabs and DNA-based next-generation sequencing. The mother and maternal uncle are carriers; the father is wild-type. The younger twin carried additional somatic NF1 and KRAS mutations. Outcomes: The elder twin achieved complete remission and has remained disease-free for 42 months. The younger twin relapsed during maintenance therapy and underwent allogeneic hematopoietic stem cell transplantation from their uncle (non-carrier,their father's younger brother), achieving remission. Conclusion: The successive occurrence of ALL-B with germline ETV6:c.744del mutation in the twins suggests genetic susceptibility to the disease. The frameshift mutation of ETV6:c.744del may serve as a potential driving factor. It is recommended that germline genetic testing and family screening be conducted for all pediatric patients with familial clustering of leukemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.